COMPARATIVE EVALUATION OF THREE DEXMEDETOMIDINE DOSES COMBINED WITH LOW-DOSE 0.5% HYPERBARIC BUPIVACAINE FOR SPINAL ANESTHESIA DURING TURP: A RANDOMIZED, DOUBLE-BLIND CLINICAL STUDY
Main Article Content
Keywords
Dexmedetomidine, Hyperbaric Bupivacaine. Spinal Anesthesia, TURP
Abstract
Background: The talking anesthesia technique has been the choice of conducting transurethral resection of the prostate (TURP), partly because it is safe and effective. Hyperbaric bupivacaine has slowly assumed the role of preference since older agents such as cinchocaine, despite their usefulness, are not as long-lasting as their counterparts, and highly expensive and restricted to a patient position.
Study design: Randomized double-blind
Duration and place of study: this study was conducted in Liaquat National Hospital and Medical College Karachi from January 2024 to January 2025
Objectives: This study aims at the evaluation as well as the comparison of the clinical effects of three different doses of intrathecal dexmedetomidine when combined with 0.5% hyperbaric bupivacaine in patients undergoing TURP.
Methods: This study is a randomised, double-blind clinical trial involving 120 male subjects of age 55-70 years who were about to undergo elective TURP. Random selection of three equal groups was received by the participants. Group A was given 0.5% hyperbaric bupivacaine 1.5 ml (7.5 mg) and dexmedetomidine 6 mcg. Group C was given 10 mcg dexmedetomidine along with bupivacaine and Group B was given 8 mcg dexmedetomidine with the same amount of bupivacaine. Researchers observed the time and duration to occurrence of sensory and motor block. Pain relief after operations involved morphine. The Numeric Rating Scale (NRS) of pain, total morphine use, and time until first rescue analgesia were recorded at 6, 8, and 12 hours.
Results: There is no statistically significant difference between the sensory and motor block length and onset of Groups A and B. In comparison with A and B, the Group C showed a significantly faster onset of block (P < 0.05). Also, the time whose first analgesic need occurred was considerably longer in Group C in comparison with Groups A and B, and it was longer in Group B in comparison with the group A (P < 0.05). Also, the total consumption of morphine during the study, as well as the NRS scores, were the lowest in the Group C at every registered point subsequent to the Group B and the highest in the Group A (P < 0.05).
Conclusion: The addition of 10 mcg of dexmedetomidine to 0.5 percent hyperbaric bupivacaine mixture has a drastic effect on the quality and the duration of spinal anesthesia used in TURP surgery with a high degree of analgesia and low opioid demand. In increasing the doses, the efficacy rises but the incidence of adverse effects does not improve with high doses in comparison with low ones.
References
2. Gravas S, Cornu JN, Gacci M, et al. EAU Guidelines on the Management of Non-neurogenic Male LUTS, incl. BPH. Eur Urol. 2021.
3. Manohar N, Goel L, Muneer M. Comparative analysis of general and spinal anesthesia in TURP. J Clin Diagn Res. 2018;12(3):UC05–7.
4. D'Angelo R, Crowley M, Ramanathan S. Anesthetic considerations in the elderly. Anesth Analg. 1998;86(1):210–16.
5. McCartney CJ, McLeod GA, Ahmed A. Should spinal anesthesia be used in the elderly? Curr Opin Anaesthesiol. 2007;20(5):538–42.
6. Pöpping DM, Elia N, Marret E, Wenk M, Tramèr MR. Protective effects of epidural analgesia on surgical mortality: a meta-analysis. Lancet. 2008;372(9638):1271–83.
7. Gupta A, Kaur S. Comparative evaluation of two doses of bupivacaine in spinal anesthesia. Indian J Anaesth. 2014;58(4):409–13.
8. Singh D, Verma A, Jaiswal G. Use of low dose bupivacaine in geriatric patients. Anesth Essays Res. 2019;13(2):358–62.
9. Kanazi GE, Aouad MT, Jabbour-Khoury SI, et al. Effects of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand. 2006;50(2):222–27.
10. Al-Mustafa MM, Abu-Halaweh SA, Aloweidi AS, et al. Effect of dexmedetomidine added to spinal bupivacaine. Eur J Anaesthesiol. 2009;26(6):524–29.
11. Bajwa SJ, Kaur J, Singh A, et al. Dexmedetomidine and clonidine as adjuvants in intrathecal anesthesia. Saudi J Anaesth. 2011;5(4):365–70.
12. Harsoor SS. Dexmedetomidine in anaesthesia practice: A wonder drug? Indian J Anaesth. 2011;55(4):323–24.
13. Gupta R, Verma R, Bogra J, et al. Dexmedetomidine as an intrathecal adjuvant. Indian J Anaesth. 2011;55(4):347–51.
14. Sethi BS, Samuel M, Sreevastava D. Efficacy of dexmedetomidine in spinal anesthesia. Indian J Anaesth. 2007;51(5):439–42.
15. Eid HE, Shafie MA, Youssef H. Dose-response study of intrathecal dexmedetomidine. Pain Physician. 2017;20(2):E207–14.
16. Shaikh SI, Mahesh SB. Dexmedetomidine as adjuvant to hyperbaric spinal bupivacaine: A randomized controlled study. Anaesth Pain Intensive Care. 2014;18(2):180–85.
17. Al-Ghanem SM, Massad IM, Al-Mustafa MM, Al-Zaben KR, Qudaisat IY, Qatawneh AM, et al. Effect of adding dexmedetomidine versus fentanyl to intrathecal bupivacaine on spinal block characteristics in gynecological procedures. Am J Appl Sci. 2009;6(5):882–87.
18. Tekin M, Kati I, Tomak Y, Yuca M, Dikmen B. Comparison of clonidine or dexmedetomidine as adjuncts to spinal anesthesia in elderly patients. Saudi Med J. 2007;28(5):698–703.
19. Harsoor SS, Rani DD, Yalamuru B, Sudheesh K, Nethra SS. Efficacy of dexmedetomidine as an adjuvant to bupivacaine spinal anesthesia in lower abdominal surgeries: A dose-response study. J Anaesthesiol Clin Pharmacol. 2015;31(1):36–40.
20. Subramanian S, Ponnusamy R, Kumar S, Rajendran R. Comparative evaluation of different doses of intrathecal dexmedetomidine in lower abdominal surgeries. J Clin Diagn Res. 2017;11(1):UC05–08.
21. Chinnappa J, Shivanna S, Pujari V, Sateesh G, Rao N. Randomized controlled study comparing the efficacy of dexmedetomidine and fentanyl as adjuvants to intrathecal bupivacaine. Anesth Essays Res. 2015;9(2):139–42.